This one-hour webinar explored the impact of generic and specialty drugs (including biosimilars) on employer costs for 2018. Attendees heard about new drugs in the pipeline that employers should start thinking about — from a coverage and cost standpoint. They also learned about plan design features employers should consider to help manage future drug trends.
- Gregory I. Madsen, Co-CEO, Innovative Rx Strategies, LLC
- Michael J. Staab, J.D., Co-CEO, Innovative Rx Strategies, LLC
Continue by clicking on the following link: